Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Defining the mechanisms of the glycophagy shunt and its role in metabolism

$3.55M USD

Funder NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
Recipient Organization Lsu Pennington Biomedical Research Ctr
Country United States
Start Date Aug 01, 2024
End Date Jun 30, 2029
Duration 1,794 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10934905
Grant Description

Project Summary / Abstract Glucose metabolism is tightly regulated and has a central role in cell biology, while dysregulated glucose metabolism is a common occurrence in various metabolic diseases such as cancer, heart disease, diabetes, and brain disease. Most glucose that enters a cell is shuttled through glycogen prior to re-entering the glycolytic

pathway, in a cycle known as the glycogen shunt. An important aspect of the glycogen shunt is glycogen degradation, a compartment specific process that occurs either within the cytosol or lysosomes. The enzymes glycogen debranching enzyme and glycogen phosphorylase mediate glycogenolysis in the cytosol, a process

that has been extensively studied and is well characterized in metabolism. However, the contribution of glycogen autophagy (glycophagy) to metabolism and the glycogen shunt has not been characterized. Given the importance of glycogen metabolism in health and disease and the lack of fundamental knowledge of glycophagy,

the overall vision for my lab over the next five years is to better decipher the mechanisms of glycophagy and its contribution to the glycogen shunt and cell metabolism. We will utilize novel genetically modified cells and mice that we have developed to study glycophagy. Additionally, we will establish new innovative tools that can be

leveraged to gain a better grasp of glycophagy in cell biology. The freedom and flexibility offered by the R35 grant mechanism will allow us to develop and employ these innovative tools that will enable influential discoveries in glycophagy research. This fundamental understanding of glycophagy in metabolism that this work will provide

will benefit a broad array of genetic and metabolic diseases where glycogen metabolism is involved, such as Pompe disease, Danon disease, cancer, heart disease, diabetes, and brain disease. I will also advance my plan for enhancing diverse perspectives during this award period. This will include forging strong transdisciplinary

collaborations to add unique expertise to help address our scientific questions. Moreover, I plan to recruit and hire lab staff from historically underrepresented groups and varying scientific fields and provide them with an array of training and mentoring opportunities to help them reach their personal and career goals.

All Grantees

Lsu Pennington Biomedical Research Ctr

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant